20 Participants NeededMy employer runs this trial

Supraglottic Airway for Premature Babies

(SUPREEMIE Trial)

SL
Overseen BySura Lee
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores the effectiveness of a supraglottic airway (a type of breathing tube) in helping premature babies breathe immediately after birth. It focuses on babies born between 29 and 33 weeks who require breathing assistance. The trial seeks to determine if this method is effective during the critical moments following birth. Babies needing breathing support at birth and meeting the gestational age criteria may be suitable candidates for this trial. As an unphased trial, it provides a unique opportunity to contribute to important research that could enhance breathing support for premature babies.

What prior data suggests that using a supraglottic airway for premature infants is safe?

Research has shown that supraglottic airways (SGAs) are generally safe and effective for newborns needing breathing assistance. These devices, positioned above the voice box, are easy to use and safe for newborns requiring support. A national resuscitation registry report, which included 281 infants, also supported the use of SGAs in newborn resuscitation.

For younger infants, including those under two months old, SGAs have proven to be a safe and effective method for breathing assistance. These findings suggest that SGAs are well-tolerated in newborns, even those born prematurely. While more research is needed, current evidence supports the safety of using supraglottic airways in these vulnerable infants.12345

Why are researchers excited about this trial?

Unlike the standard of care, which usually involves endotracheal intubation or bag-mask ventilation for premature babies needing immediate breathing support, the supraglottic airway offers a novel approach. This treatment is unique because it uses a specialized device placed above the vocal cords to deliver ventilation, potentially simplifying the process of providing positive pressure ventilation. Researchers are excited about this technique because it could make resuscitation quicker and less invasive, reducing the risk of trauma and complications associated with traditional methods. This innovation might streamline emergency care in the delivery room, making it a promising option for improving outcomes in these vulnerable infants.

What evidence suggests that using a supraglottic airway is effective for resuscitating premature infants?

Research has shown that certain devices called supraglottic airways (SGAs) effectively help newborns breathe. Studies indicate that SGAs can outperform traditional facemasks in newborn resuscitation. They have successfully assisted newborns, including those born prematurely, in obtaining sufficient oxygen and breathing properly. Additionally, SGAs have reduced the need for more invasive procedures, such as inserting a tube into the windpipe, in full-term newborns. In this trial, premature infants requiring positive pressure ventilation immediately after birth will receive ventilation through a supraglottic airway, suggesting that SGAs could be a promising option for helping premature babies breathe right after birth.14678

Are You a Good Fit for This Trial?

Inclusion Criteria

Parental informed consent
Gestational age 29 0/7 to 33 6/7 weeks at birth
Estimated fetal weight >/= 1000 grams at birth
See 1 more

Exclusion Criteria

I am planning or considering palliative care.
Not resuscitated in the infant resuscitation room
I have major genetic abnormalities or extra/missing chromosomes.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

Prenatal and on the day of delivery
2 visits (prenatal and on delivery day)

Intervention

Participants receive positive pressure ventilation using a supraglottic airway during delivery room resuscitation

Up to 10 minutes after birth
1 visit (immediately after birth)

Follow-up

Participants are monitored for clinical and procedural data collection during delivery room resuscitation and for up to 24 hours after birth

24 hours
Continuous monitoring

What Are the Treatments Tested in This Trial?

Interventions

  • Supraglottic Airway

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Supraglottic AirwayExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

Citations

Preterm Supraglottic Airways Succeed in Neonatal ... - PMC

SADs have proven effective for achieving PPV in term neonates, potentially reducing the need for ETI. International Neonatal Resuscitation ...

Surfactant Therapy Via Supraglottic Airway to Preterm ...

The study will include preterm babies born before 34 weeks of pregnancy and weighing at least 750 grams, at Phu San Hanoi Hospital in Vietnam. If SALSA is found ...

Use of supraglottic airways in neonates and infants less ...

Oxygenation and ventilation via SGA were successful in four of these cases, facilitating return of spontaneous circulation, including in two preterm neonates ...

4.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/41147710/

Preterm Supraglottic Airways Succeed in Neonatal ...

Conclusion: Preterm-sized supraglottic airway devices appeared feasible for simulated neonatal resuscitation. Further clinical studies are ...

Comparison of supraglottic airway device and ...

We aim to compare the perioperative respiratory adverse events between using supraglottic airway device (SAD) and ETT in former preterm infants receiving ...

Supraglottic airway use during neonatal resuscitation

A recent publication reporting outcomes for infants included in a national resuscitation registry included 281 infants receiving a first dose of ...

Supraglottic airway use in neonates and young infants

1. SGAs would be infrequently used among patients under 2 months of age. 2. SGAs would be a safe, efficacious airway management ...

Preterm Supraglottic Airways Succeed in Neonatal ...

This study aimed to evaluate ventilation outcomes in manikins to determine whether progression to clinical testing is warranted. Methods. This ...